Back
Cognition Therapeutics 10K Form
Sell
33
CGTX
Cognition Therapeutics
Last Price:
0.40
Seasonality Move:
14.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CGTX News And Ratings
See the #1 stock for the next 7 days that we like better than CGTX
CGTX Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-6.85M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.35 |
| Price / Book: | 1.16 |
Profitability
| EPS (TTM): | -0.97000 |
|---|---|
| Net Income (TTM): | $-34.27M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Cognition Therapeutics Earnings Forecast
Key Cognition Therapeutics Financial Ratios
- The Interest Expense is -0.10% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 2 years.
Cognition Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | CGTX |
| Website: | cogrx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
CGTX Technical Analysis vs Fundamental Analysis
Sell
33
Cognition Therapeutics (CGTX)
is a Sell
Is Cognition Therapeutics a Buy or a Sell?
-
Cognition Therapeutics stock is rated a Sell
The current Cognition Therapeutics [CGTX] share price is $0.40. The Score for CGTX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.